JP3790792B2 - Simple determination method of risk of squamous cell carcinoma occurrence by exhalation and apparatus for the same - Google Patents

Simple determination method of risk of squamous cell carcinoma occurrence by exhalation and apparatus for the same Download PDF

Info

Publication number
JP3790792B2
JP3790792B2 JP2002011053A JP2002011053A JP3790792B2 JP 3790792 B2 JP3790792 B2 JP 3790792B2 JP 2002011053 A JP2002011053 A JP 2002011053A JP 2002011053 A JP2002011053 A JP 2002011053A JP 3790792 B2 JP3790792 B2 JP 3790792B2
Authority
JP
Japan
Prior art keywords
risk
cell carcinoma
squamous cell
occurrence
determination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002011053A
Other languages
Japanese (ja)
Other versions
JP2003215123A (en
Inventor
学 武藤
浩安 江角
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
National Cancer Center Japan
National Institute of Japan Science and Technology Agency
Original Assignee
Japan Science and Technology Agency
National Cancer Center Japan
National Institute of Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency, National Cancer Center Japan, National Institute of Japan Science and Technology Agency filed Critical Japan Science and Technology Agency
Priority to JP2002011053A priority Critical patent/JP3790792B2/en
Publication of JP2003215123A publication Critical patent/JP2003215123A/en
Application granted granted Critical
Publication of JP3790792B2 publication Critical patent/JP3790792B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Description

【0001】
【発明の属する技術分野】
この出願の発明は、被験者の扁平上皮癌発生危険度を判定するための簡易判定方法とそのための判定用装置に関するものである。さらに詳しくは、この出願の発明は被験者の呼気中のアセトアルデヒド濃度の経時変化から、該被験者が扁平上皮癌を発生する危険度を判定する簡易判定方法と簡易判定装置に関するものである。
【0002】
【従来技術とその課題】
癌による死者は、1990年には世界で約520万人であったが、2010年には、800万人に近づくと推計されており(Pisani, P., Parkin, D.M., Bray, F., Ferlay, J., Int. J. Cancer 83, 18-29 (1999))、日本国内でも2000年に癌による死者の数は30万人に近づいた(厚生労働省 平成12年人口動態統計)。これは脳血管疾患による死者と心疾患による死者を合わせた人数よりも多い。また、部位別に見れば、気管・気管支および肺癌の人数が最も多く約5万4千人、次いで胃癌で5万人となっている。したがって、癌対策は世界的にも疾病対策において最重要課題の1つと位置づけられており、その治療薬や治療法についての研究が様々な角度からなされている。
【0003】
最近の研究により、口腔・咽頭癌、食道癌、肺癌と喫煙の関係、皮膚癌と紫外線の関係等については、一般的に認識されるようになっている(例えば、国立がんセンター「がんの統計」'99)。また、近年では、飲酒が各種疾患に与える影響についても明らかになってきており、癌に関してもこれまでに、過度の飲酒により口腔・咽頭癌、食道癌の危険性が高まることが明らかにされている(例えば、H.K.Seitz, S.Matsuzaki, A.Yokoyama, N.Homann, S.Vakevainen, and X.D.Wang, Alcoholism: Clinical and Experimental Research, Vol.25, No.5, 2001; S.Franceschi, F.Levi, C.LaVecchia, E.Conti, L.DalMaso, L.Barzan, and R.Talamini, Int.J.Cancer 83, 1-4, 1999)。しかし、アルコールは古くから「百薬の長」などと称され、発癌との関係については一般的にあまり認知されていないのが実情である。
【0004】
したがって、癌に対する国民の関心は高いものの、実際にどのような人がどのような健康管理をすればよいのかといった具体的な予防策については、現在のところ知られていないのが実情である。個人が癌発症の危険性が高い危険群に入るか否か知る手段、すなわち癌危険群を判定・診断する精度高い方法があれば、医師から患者への予防策の指導や本人の生活習慣の改善に対する意識も高まると期待される。
【0005】
しかし、このような診断方法が煩雑な操作や被験者の苦痛を伴う場合、費用が高くなる場合、あるいは診断までに長期間を有する場合には、普及率が低くなることも考えられる。
【0006】
この出願の発明は、以上のとおりの問題点を解決し、アルコールによる発癌の高危険群、とくに扁平上皮癌発生の高危険群を判定、診断するための簡便な方法を提供することを課題としている。
【0007】
【課題を解決するための手段】
この出願の発明は、以上のとおりの課題を解決するものとして、第1には、一定濃度のアルコールを一定量摂取した後、呼気中のアセトアルデヒド濃度の経時変化を測定し、アセトアルデヒド濃度の急激な上昇が見られた場合や、時間経過によるアセトアルデヒド濃度の減少度が小さい場合に、扁平上皮癌発生危険度が高いと判定することを特徴とする扁平上皮癌発生危険度の簡易判定方法を提供する。
【0008】
この出願の発明は、第2には、一定濃度のアルコールを一定量摂取した後、呼気中のアセトアルデヒド濃度の経時変化を測定し、30分以内にアセトアルデヒド濃度が10nmol以下にならないとき、扁平上皮癌発生危険度が高いと判定する扁平上皮癌発生危険度の簡易判定方法を提供する。
【0009】
また、第3には、この出願の発明は、呼気により扁平上皮癌発生の危険度を判定するための簡易判定用装置であって、少なくとも、
一定濃度のアルコールを一定量摂取した後の被験者からの呼気が導入される呼気導入部と
導入された呼気のアセトアルデヒド濃度を経時的に測定するアセトアルデヒド濃度測定部と
アセトアルデヒド濃度の経時的変化から扁平上皮癌発生の危険度を判定するための危険度判定部と
この判定のための指標を設定し、危険度判定部に伝える危険度指標設定部と、
危険度判定部からの判定結果を表示する判定表示部とを有し、
危険度指標設定部においては、アセトアルデヒド濃度が経時変化の過程で急激な上昇かもしくは所定の減少度より小さい減少度を示す場合に、危険度が高いとして指標設定されていることを特徴とする扁平上皮癌発生危険度の簡易判定用装置を提供する。
【0010】
そして、この出願の発明は、第4には、30分以内にアセトアルデヒド濃度が10nmol以下になることを所定の減少度とする前記の扁平上皮癌発生危険度の簡易判定用装置をも提供する。
【0011】
【発明の実施の形態】
この出願の発明者らは、これまで、とくに頭頸部癌と食道癌を併発する多重癌患者を対象に発癌機構を研究してきた。そして、頭頸部癌と食道癌の両者を併発する患者の食道粘膜に健常者では見られない多発異型上皮が発生することを発見し、報告した(Muto et al. Gut. 2000 Aug; 47(2): 256-261)。
【0012】
発明者らの鋭意研究によれば、このような多発異型上皮は多重癌患者の中でもアルコールを嗜好する患者にのみ見られることから、多発異型上皮癌と飲酒の関係が示唆された。ところが、アルコールを大量に摂取していても全く多発異型上皮が見られない患者も約2/3おり、さらにアルコール摂取量と多発異型上皮の発生にも関連性が見られなかった。
【0013】
そこで、この出願の発明者は、患者のアルコール代謝能力に着目し、アルコール代謝に関わる二つの酵素、アルコール脱水素酵素(ADH)とアルデヒド脱水素酵素(ALDH)の遺伝子多型を調べた。それぞれの酵素は遺伝子多型によって異なることが知られているが、発明者らは、これら2つの酵素の遺伝子多型の組み合わせにより、多発異型上皮の発生頻度が大きく異なることを見出した。
【0014】
ヒトのアルコール脱水素酵素(ADH)にはADH1、ADH2およびADH3の3つの異性体が存在することが知られている。中でもADH3には、アルコール代謝速度の速いADH3−1アリルのホモ接合体(ADH3*1/3*1)とアルコール代謝速度の遅いADH3−2アリル(ADH3*1/3*2およびADH3*2/3*2)が存在する。(A.F.Olshan, M.C.Weissler, M.A.Watson and D.A.Bell; Carcinogenesis vol.22 no.1 pp.57-61, 2001)
一方、アルコール分解により生成されるアセトアルデヒドをさらに分解するアルデヒド脱水素化酵素(ALDH)では、アルデヒドが高濃度の際に働くALDH1と、低濃度のアルデヒドをも分解できるALDH2があることが知られている。
【0015】
ALDH2遺伝子多型には、活性なALDH2−1アリル(ALDH2*1/2*1)と不活性なALDH2−2アリル(ALDH2*1/2*2およびALDH2*2/2*2)があり、飲酒により顔面が赤くなるなどのフラッシング反応が起こり易い人は、ALDH2−2アリルを有することが知られている。また、ALDH2−2アリルは、西洋人には見出されておらず、アジアの民族にのみ存在することが知られている。(H.K.Seitz, S.Matsuzaki, A.Yokoyama, N.Homann, S.Vakevainen, and X.D.Wang; Alcoholism: Clinical and Experimental Research, Vol.25, No.5)
この出願の発明者らは、重複癌患者において、ADH3−2アリルとALDH2−2アリルの両方を有する患者の約85%が多発異型上皮を有することを見出し、細胞染色体中のADH3−2アリルおよびALDH2−2アリルを検出する多発扁平上皮癌危険群の判定方法を提供している。
【0016】
このような判定方法は、非常に精度が高く、現在行われている「人間ドック」や「定期健康診断」などにおいて、癌検診の一項目として実施すれば社会的にも受け入れやすく、癌予防への一般の意識も向上すると考えられることから、非常に有用である。
【0017】
しかし、実際の診断には、例えば内視鏡検査による咽喉や食道からの正常細胞の採取、末梢血リンパ球からのDNAの抽出、ポリメラーゼ連鎖反応−制限断片長多型(PCR−RFLP)等によるADH3−2アリルとALDH2−2アリルの検出など複数のステップがあり、判定までに数日を要する。また、遺伝子診断用の分析装置が必要なため、診断費用も高くなり易く、小規模な医院や診療所で迅速に判定を行うことは難しい。さらに、多くの企業等は、一定年齢以上の従業員に対してのみ人間ドックや内視鏡検査を含む健康診断を実施しており、それ以下の年齢の者がこのような検診を受ける機会は実質的にあまりない。しかし、若年層の癌患者も増加しており、癌予防や生活習慣の改善は、年齢に関わらず重要な課題である。したがって、遺伝子検査を行うことなく、より簡便に扁平上皮癌危険群をスクリーニングする方法があれば、なお好ましいといえる。
【0018】
発明者らは、頭頚部癌と食道癌を併発した患者にアルコール負荷させ、呼気中のアセトアルデヒド濃度を測定したところ、その値とADH3およびALDH2の遺伝子多型の組み合わせに相関があることを見出し、本願発明に至ったものである。
【0019】
すなわち、この出願の発明の扁平上皮癌発生危険度の簡易判定方法では、一定濃度のアルコールを一定量摂取した後、呼気中のアセトアルデヒド濃度の経時変化を測定し、アルデヒド濃度が急激に上昇するか、時間経過による減少度が小さい場合に、扁平上皮癌発生危険度が高いと判定する。
【0020】
このような簡易判定方法では、予め被験者が摂取したアルコールが体内で分解され、アセトアルデヒドとなって呼気中に排出される。そのとき、アルコール摂取直後のアセトアルデヒド濃度の急激な上昇が見られる場合や、時間経過に伴うアセトアルデヒド濃度の減少度が小さい場合には、ADH3−2アリルとALDH2−2アリルの両方を有すると判断できる。
【0021】
発明者らの研究によれば、等量のアルコールを同じ時間かけて摂取した際の呼気中のアセトアルデヒド濃度は、被験者における遺伝子多型の組み合わせが、ADH3−2(−)/ALDH2−2(−)、ADH3−2(+)/ALDH2−2(−)、ADH3−2(−)/ALDH2−2(+)、ADH3−2(+)/ALDH2−2(+)の順に高くなる。後述の実施例からも明らかなように、その差は明確である。
【0022】
したがって、基準値を設け、呼気中のアルデヒド濃度が該基準値以上となる場合、あるいは、一定時間内に基準値以下とならない場合に扁平上皮癌発生危険度が高いと判定すればよい。このような判定の基準値は、遺伝子多型の組み合わせが、ADH3−2(−)/ALDH2−2(−)、ADH3−2(+)/ALDH2−2(−)、ADH3−2(−)/ALDH2−2(+)、ADH3−2(+)/ALDH2−2(+)である被験者について、同条件下で網羅的に測定を行い、その結果を元に設定されることが好ましい。例えば、発明者らの研究結果に基づけば、6%アルコールを200ml摂取した後、30分経過後も呼気中のアセトアルデヒド濃度が10nmol以下にならない場合に、扁平上皮癌発生の危険度が高いと判定できる。もちろん、基準値は、被験者の年齢、性別、人種等に応じて適宜設定してもよい。
【0023】
この出願の発明は、さらに、呼気中のアセトアルデヒド濃度から扁平上皮癌の危険度を判定するための簡易判定用装置をも提供する。このような簡易判定用装置は、図1に示すとおりの構成を有する。すなわち、少なくとも、
(a)一定濃度のアルコールを一定量摂取した後の被験者からの呼気が導入される呼気導入部と
(b)導入された呼気のアセトアルデヒド濃度を経時的に測定するアセトアルデヒド濃度測定部と
(c)アセトアルデヒド濃度の経時的変化から扁平上皮癌の危険度を判定するための危険度判定部と
(d)この判定のための指標を設定し、危険度判定部に伝えるための危険度指標設定部と、
(e)危険度判定部からの判定結果を表示する判定表示部
を有するものとする。また、このような簡易判定用装置において、(d)の危険度指標設定部では、アセトアルデヒド濃度が経時変化の過程で急激に上昇する場合やアセトアルデヒド濃度の減少度が所定の値より小さい場合が「危険度が高い」ことの指標として設定されている。
【0024】
この出願の発明の扁平上皮癌発生危険度の簡易判定用装置において、呼気は、被験者に一定濃度のアルコールを一定量摂取させた後、例えばガスサンプリング用の市販のサンプルバッグに息を吹き込ませて採取できる。あるいは、簡易判定用装置の呼気導入部が直接息を吹き込めるようなマウスピースを有する場合には、該マウスピースに口を当てて被験者が息を吹き込んでもよい。このとき、採取される呼気の量はとくに限定されない。被験者に大きな負担を強いない程度の量であればよく、アセトアルデヒド濃度測定部の検出感度等に応じて適宜変更できる。
【0025】
サンプルバッグに呼気を採取する場合には、この出願の発明の簡易判定用装置における呼気導入部(a)は、シリンジでサンプルバッグから呼気を抜き出し、該シリンジを差し込み、採取された呼気を注入できる差し込み注入口であってもよいし、活栓等を介してサンプルバッグを直接連結できるような構造を有するものであってもよい。一方、呼気を簡易判定用装置に直接吹き込む場合には、マウスピースは、口に含み息を吹き込むための細径のチューブやストローであってもよいし、口にあてて息を吹き込むフェイスマスクであってもよい。これらは衛生面からも取外し可能とし、殺菌消毒可能、あるいは使い捨てとすることが好ましい。もちろん、これらのサンプルバッグやマウスピースは、フィルター、活栓、一方弁等を有するものであってもよい。
【0026】
導入された呼気は、次に、アセトアルデヒド濃度測定部(b)に移送され、アセトアルデヒド濃度が経時的に測定される。このとき、呼気は、窒素、アルゴンなどの不活性ガス等をキャリアガスとして呼気導入部からアセトアルデヒド濃度測定部に移送されてもよいし、呼気がそのまま対流、拡散するものとしてもよい。このようなアセトアルデヒド濃度測定部は、アセトアルデヒドの濃度を測定できるものであれば、どのような構成、構造のものであってもよく、とくに限定されない。具体的には、Breath Gas Analyzerをアセトアルデヒド用に改良したもの、ガスクロマトグラフィー、ガス検知管、試薬塗布水晶張動子などが例示される。
【0027】
Breath Gas Analyzerは、従来乳糖消化吸収障害や糖尿病性胃腸障害の診断に使用されており、呼気中の水素とメタンの濃度を測定する装置である。この検出部をアセトアルデヒド用に改良すれば、本願発明の簡易判定装置用のアセトアルデヒド濃度測定部(b)として適用できる。一方、ガスクロマトグラフィーは、ステンレス製やガラス製のカラムに、モレキュラーシーブス、シリカゲル、多孔質樹脂ビーズなどの充填剤を充填し、ガスを流通させた際の各成分の吸・脱着速度の差によりガスを分離、分析、定量する方法であり、各種のカラムパックからアセトアルデヒドの分析に適当なものを選択できる。また、ガス検知管は、特定の試薬と気体の反応によって生じる色調変化をもとに濃度を分析する簡易法であり、黄→赤などの色調変化により、アセトアルデヒド濃度0.1ppm〜20ppmの測定範囲で1〜10時間測定できるものなど多種多様のものが市販されている。ガス検知管は繰り返しの使用ができないため、毎回使い捨てになるが、測定範囲に応じた量の呼気が採取できるならば、簡便で有効な手段といえる。さらに、試薬塗布水晶張動子は、アセトアルデヒドと特異的に反応するシッフ塩基等の試薬を振動子の表面に塗布し、アセトアルデヒドが反応した場合に生じる発振周波数の変化を検出するものである。この出願の発明では、中でもアセトアルデヒド濃度測定部として、測定精度が高く、測定濃度範囲も広いガスクロマトグラフィーが好ましく用いられる。
【0028】
以上のとおりのアセトアルデヒド濃度測定部(b)における測定結果は、信号伝送手段により、電気信号等として危険度判定部(c)に伝送される。そして、この危険度判定部(c)において、アセトアルデヒド濃度の経時的変化から扁平上皮癌発生の危険度が判定される。
【0029】
このような危険度判定部(c)は、例えばコンピューターとすることができ、アセトアルデヒド濃度測定部(b)で測定された呼気中のアセトアルデヒド濃度の経時変化の値を危険度指標設定部位(d)に入力設定された指標と対比、判定できるものである。危険度指標設定部位(d)に入力設定される危険度の指標は、遺伝子多型の組み合わせが、ADH3−2(−)/ALDH2−2(−)、ADH3−2(+)/ALDH2−2(−)、ADH3−2(−)/ALDH2−2(+)、ADH3−2(+)/ALDH2−2(+)である被験者について、同条件下で網羅的に測定を行い、その結果を元に設定できる。また、被験者の年齢、性別、人種等に応じて随時設定変更でき、とくに限定されない。
【0030】
このような危険度指標設定部位(d)では、アセトアルデヒド濃度が、経時変化の過程で急激な上昇や所定の減少度より小さな減少度を示す場合に、危険度が高いものと設定される。発明者らの鋭意研究によれば、6%アルコールを200ml摂取した後、30分経過後も呼気中のアセトアルデヒド濃度が10nmol以下にならない場合に、扁平上皮癌発生危険度が高いものと設定できる。
【0031】
そして、この判定結果は、さらに、信号伝送手段により判定表示部(e)に伝達され、表示される。このとき、判定表示部(e)としては、液晶モニターやCRTモニターのように、数値やグラフなどが画像として表示されるもの、スピーカーのように音声が出力されるもの、さらには、プリンターのように紙面に結果が印刷されるもの等が例示される。
【0032】
以上のとおりの扁平上皮癌発生危険度の簡易判定用装置は、少なくとも以上のとおりの構成を有するものであるが、他にも被験者の呼気吹き込みを指示する音声、文字、信号、画像等を発する手段や測定進捗状況を被験者や操作担当者に示す表示手段等を有していても良い。このような簡易判定用装置は、各構成部を小型化することにより、移動や携帯が可能なものとすることができる。これにより上皮癌発生危険度を定量的に、現場で迅速かつ簡便に、精度高く測定することが可能となる。
【0033】
【実施例】
<実施例1>
食後2時間以上経過した被験者78人に、6%のアルコールを含有するグレープフルーツジュース200mlを10分間かけて摂取させた。78人中、26人は、強いアルコール不耐性を示したため、検査に参加できなかった。
【0034】
したがって、残りの52人について、アルコール摂取前、摂取直後、10分後、30分後に呼気回収パックにて呼気を採取し、ガスクロマトグラフィー(カラム:ポラパック Q60/80 ガラスカラム 3mm×2m;GL Science社、検出器:FID、キャリアガス:ヘリウム、流量:40mlmin)により呼気1ml中のアセトアルデヒド濃度を分析した。
【0035】
結果を図2に示した。
【0036】
アルコール摂取前には全く検出されなかったアセトアルデヒドが、飲酒直後から検出されるようになった。また、遺伝子多型アリルの組み合わせにより、そのピーク値と10分後、30分後の値に差が見られた。
【0037】
具体的には、遺伝子多型の組み合わせがADH3−2(−)/ALDH2−2(−)、ADH3−2(+)/ALDH2−2(−)、ADH3−2(−)/ALDH2−2(+)、ADH3−2(+)/ALDH2−2(+)の順にアセトアルデヒド濃度が高くなることが示された。
【0038】
多発異型上皮の発生危険率も同様の順に有意に増加することから、呼気中のアセトアルデヒド濃度の測定により、扁平上皮癌の発生危険率を的確に予測できることが示された。また、多発癌の高危険群をも精度高く見出せることが示された。すなわち、図2に示したように、遺伝子多型の組み合わせがADH3−2(−)/ALDH2−2(−)およびADH3−2(+)/ALDH2−2(−)では、30分経過後の呼気中のアセトアルデヒド濃度が10nmol以下となり、扁平上皮癌の発生危険率が低いと判定できた。一方、遺伝子多型の組み合わせがADH3−2(−)/ALDH2−2(+)およびADH3−2(+)/ALDH2−2(+)では、30分経過後でも、呼気中のアセトアルデヒド濃度は10nmol以下とならない(両者ともに、50nmol以上を維持)ことから、扁平上皮癌の発生危険率が高いと判定することができた。
【0039】
【発明の効果】
以上詳しく説明したとおり、この出願の発明により、被験者が扁平上皮癌発生の危険度を、呼気中のアルデヒド濃度を測定することにより診断できる簡便な判定方法と判定用装置が提供される。
【0040】
このような扁平上皮癌発生危険度の判定方法は、遺伝子検査を必要とせず、短時間に定量的で非侵襲的な評価が可能な上、高価な遺伝子分析用の装置や煩雑な操作を必要としないことから、小規模の医院や診療所での導入も容易であり、社会に受け入れられやすく、癌予防の社会的関心を高めることが期待される。
【0041】
また、本願の扁平上皮癌発生危険度の判定用装置により、簡便に扁平上皮癌発生の危険度が測定できるようになるだけでなく、小型化することにより携帯可能な簡易判定用装置が得られる。このような小型簡易判定装置により、あらゆる医療現場で迅速に扁平上皮癌発生危険度を判定することが可能となり、癌予防がより一般的に浸透すると期待される。
【0042】
発癌の危険性が高いか否かを被験者自身が認識すれば、具体的で効果的な癌予防に取り組むことができるようになるため、本願発明の有用性は高い。
【図面の簡単な説明】
【図1】この出願の発明における扁平上皮癌発生危険度の簡易判定用装置の概要を示した概略図である。
【図2】この出願の発明の実施例において、アルコール摂取による呼気中のアセトアルデヒド濃度とADH3およびALDH2の遺伝子多型の組み合わせの関係を示した図である。
[0001]
BACKGROUND OF THE INVENTION
The invention of this application relates to a simple determination method for determining a subject's risk of developing squamous cell carcinoma and a determination apparatus therefor. More specifically, the invention of this application relates to a simple determination method and a simple determination apparatus for determining a risk of developing squamous cell carcinoma of a subject from time-dependent changes in acetaldehyde concentration in the breath of the subject.
[0002]
[Prior art and its problems]
The number of deaths due to cancer was estimated at around 5.2 million worldwide in 1990, but it is estimated that it will approach 8 million in 2010 (Pisani, P., Parkin, DM, Bray, F., Ferlay, J., Int. J. Cancer 83, 18-29 (1999)), the number of cancer deaths in Japan approached 300,000 in 2000 (Ministry of Health, Labor and Welfare, 2000 vital statistics). This is more than the total number of deaths from cerebrovascular disease and deaths from heart disease. Moreover, by region, the number of trachea / bronchi and lung cancer is the largest, about 54,000, followed by gastric cancer with 50,000. Therefore, cancer countermeasures are positioned as one of the most important issues in disease countermeasures worldwide, and research on therapeutic drugs and treatment methods is being conducted from various angles.
[0003]
Recent research has led to a general recognition of the relationship between oral and pharyngeal cancer, esophageal cancer, lung cancer and smoking, skin cancer and ultraviolet light, etc. Statistics "'99). In recent years, the effects of drinking on various diseases have also been clarified. Regarding cancer, it has been clarified that excessive drinking increases the risk of oral and pharyngeal cancer and esophageal cancer. (E.g., HKSeitz, S. Matsuzaki, A. Yokoyama, N. Homann, S. Vakevainen, and XDWang, Alcoholism: Clinical and Experimental Research, Vol. 25, No. 5, 2001; S. Franceschi, F. Levi, C. LaVecchia, E. Conti, L. DalMaso, L. Barzan, and R. Talamini, Int. J. Cancer 83, 1-4, 1999). However, alcohol has long been referred to as the “Hundred Drugs” and the fact is that the relationship with carcinogenesis is generally not well recognized.
[0004]
Therefore, although the public's interest in cancer is high, there are currently no known specific preventive measures such as what kind of people should actually do what kind of health care. If there is a method for knowing whether an individual is in a risk group with a high risk of developing cancer, that is, a highly accurate method for determining and diagnosing a cancer risk group, doctors will provide guidance on preventive measures and the person's lifestyle habits. It is expected that awareness of improvement will increase.
[0005]
However, when such a diagnostic method involves complicated operations or pain of the subject, the cost is high, or if the diagnosis method has a long period of time, the penetration rate may be low.
[0006]
The invention of this application is to solve the above-mentioned problems and to provide a simple method for determining and diagnosing a high risk group of carcinogenesis due to alcohol, particularly a high risk group of squamous cell carcinoma occurrence. Yes.
[0007]
[Means for Solving the Problems]
In order to solve the problems as described above, the invention of this application firstly, after ingesting a certain amount of alcohol at a certain concentration, the time-dependent change in acetaldehyde concentration in exhaled breath was measured, and the acetaldehyde concentration rapidly increased. Provided is a simple method for determining the risk of developing squamous cell carcinoma, characterized by determining that the risk of developing squamous cell carcinoma is high when an increase is seen or the degree of decrease in acetaldehyde concentration over time is small .
[0008]
Secondly, according to the invention of this application, after ingesting a certain amount of alcohol at a certain concentration, the time-dependent change in acetaldehyde concentration in the breath is measured, and when the acetaldehyde concentration does not become 10 nmol or less within 30 minutes, squamous cell carcinoma Provided is a simple determination method for the risk of occurrence of squamous cell carcinoma determined to have a high risk of occurrence.
[0009]
Third, the invention of this application is a simple determination device for determining the risk of occurrence of squamous cell carcinoma by exhalation, and at least,
A breath induction part that introduces exhaled breath from a subject after ingesting a constant amount of alcohol, an acetaldehyde concentration measurement part that measures the acetaldehyde concentration of the introduced breath over time, and squamous epithelium from changes in acetaldehyde concentration over time A risk level determination unit for determining the risk level of cancer occurrence and an index for this determination, a risk level index setting unit to be transmitted to the risk level determination unit,
A determination display unit that displays a determination result from the risk determination unit,
In the risk index setting unit, when the acetaldehyde concentration shows a rapid increase in the course of change over time or a decrease level smaller than a predetermined decrease level, the risk level is set as a high risk level. An apparatus for simple determination of the risk of occurrence of epithelial cancer is provided.
[0010]
The fourth aspect of the present invention also provides the above-described apparatus for simple determination of the risk of occurrence of squamous cell carcinoma, wherein the acetaldehyde concentration is reduced to 10 nmol or less within 30 minutes.
[0011]
DETAILED DESCRIPTION OF THE INVENTION
The inventors of this application have so far studied the mechanism of carcinogenesis, particularly in multiple cancer patients with both head and neck cancer and esophageal cancer. He also discovered and reported that multiple atypical epithelium was observed in the esophageal mucosa of patients with both head and neck cancer and esophageal cancer (Muto et al. Gut. 2000 Aug; 47 (2 ): 256-261).
[0012]
According to the inventors' earnest studies, such multiple atypical epithelium is seen only in patients who prefer alcohol among multiple cancer patients, suggesting a relationship between multiple atypical epithelial cancer and alcohol drinking. However, about 2/3 patients who did not have multiple atypical epithelium at all even if they consumed a large amount of alcohol, and there was no relationship between alcohol intake and the occurrence of multiple atypical epithelium.
[0013]
Accordingly, the inventors of this application focused on the patient's ability to metabolize alcohol, and examined gene polymorphisms of two enzymes involved in alcohol metabolism, alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). Each enzyme is known to vary depending on the gene polymorphism, but the inventors have found that the frequency of occurrence of multiple atypical epithelium varies greatly depending on the combination of the gene polymorphisms of these two enzymes.
[0014]
It is known that human alcohol dehydrogenase (ADH) has three isomers, ADH1, ADH2 and ADH3. Among them, ADH3 includes ADH3-1 allyl homozygote (ADH3 * 1/3 * 1) having a high alcohol metabolism rate and ADH3-2 allyl (ADH3 * 1/3 * 2 and ADH3 * 2 /) having a low alcohol metabolism rate. 3 * 2) exists. (AFOlshan, MCWeissler, MAWatson and DABell; Carcinogenesis vol.22 no.1 pp.57-61, 2001)
On the other hand, aldehyde dehydrogenase (ALDH), which further decomposes acetaldehyde produced by alcohol decomposition, is known to have ALDH1 that works when aldehyde is at a high concentration and ALDH2 that can also decompose a low concentration of aldehyde. Yes.
[0015]
ALDH2 gene polymorphism includes active ALDH2-1 allele (ALDH2 * 1/2 * 1) and inactive ALDH2-2 allele (ALDH2 * 1/2 * 2 and ALDH2 * 2/2 * 2), It is known that a person who is prone to a flushing reaction such as redness of the face due to drinking has ALDH2-2 allyl. Moreover, ALDH2-2 allyl is not found in Westerners and is known to exist only in Asian ethnic groups. (HKSeitz, S. Matsuzaki, A. Yokoyama, N. Homann, S. Vakevainen, and XDWang; Alcoholism: Clinical and Experimental Research, Vol. 25, No. 5)
The inventors of this application have found that about 85% of patients with both ADH3-2 allyl and ALDH2-2 allele have multiple atypical epithelium in patients with double cancer, and ADH3-2 allele in the cell chromosome and The present invention provides a method for determining a group of multiple squamous cell carcinoma risks that detects ALDH2-2 allele.
[0016]
Such a determination method is very accurate, and it can be easily accepted by society if it is implemented as an item for cancer screening in the current “clinical checkup” and “regular health checkup”. It is very useful because it is thought to improve general awareness.
[0017]
However, for actual diagnosis, for example, normal cells are collected from the throat and esophagus by endoscopy, DNA is extracted from peripheral blood lymphocytes, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), etc. There are multiple steps such as detection of ADH3-2 allyl and ALDH2-2 allyl, and several days are required for the determination. Further, since an analyzer for gene diagnosis is required, the diagnosis cost is likely to be high, and it is difficult to make a quick determination at a small clinic or clinic. In addition, many companies, etc., conduct health checkups, including physical examinations and endoscopy, only for employees over a certain age. Not very much. However, young cancer patients are also increasing, and cancer prevention and lifestyle improvement are important issues regardless of age. Therefore, it would be still preferable if there is a method for screening a squamous cell cancer risk group more easily without performing a genetic test.
[0018]
The inventors of the present invention have found that there is a correlation between the combination of ADH3 and ALDH2 gene polymorphisms when the acetaldehyde concentration in exhaled breath was measured by alcohol loading a patient who had both head and neck cancer and esophageal cancer. The present invention has been achieved.
[0019]
That is, in the simple determination method of the squamous cell carcinoma occurrence risk of the invention of this application, after ingesting a certain amount of alcohol at a certain concentration, the time-dependent change in acetaldehyde concentration in the breath is measured, and whether the aldehyde concentration rapidly increases When the degree of decrease over time is small, it is determined that the risk of occurrence of squamous cell carcinoma is high.
[0020]
In such a simple determination method, alcohol previously ingested by the subject is decomposed in the body and converted into acetaldehyde and discharged into the breath. At that time, when a rapid increase in acetaldehyde concentration immediately after alcohol intake is observed, or when the degree of decrease in acetaldehyde concentration with time is small, it can be determined that both ADH3-2 allyl and ALDH2-2 allyl are present. .
[0021]
According to the study by the inventors, the concentration of acetaldehyde in exhaled breath when ingesting an equal amount of alcohol over the same period of time is determined by the combination of genetic polymorphisms in the subject: ADH3-2 (−) / ALDH2-2 (− ), ADH3-2 (+) / ALDH2-2 (−), ADH3-2 (−) / ALDH2-2 (+), ADH3-2 (+) / ALDH2-2 (+) in this order. As is clear from the examples described later, the difference is clear.
[0022]
Therefore, a reference value is provided, and it may be determined that the risk of developing squamous cell carcinoma is high when the aldehyde concentration in exhaled air is equal to or higher than the reference value, or when it does not become lower than the reference value within a certain time. The reference value for such determination is that the combination of genetic polymorphisms is ADH3-2 (−) / ALDH2-2 (−), ADH3-2 (+) / ALDH2-2 (−), ADH3-2 (−). It is preferable that the subjects who are / ALDH2-2 (+) and ADH3-2 (+) / ALDH2-2 (+) are comprehensively measured under the same conditions and set based on the results. For example, based on the research results of the inventors, if the acetaldehyde concentration in exhaled breath does not become 10 nmol or less after 30 minutes have elapsed after ingesting 200 ml of 6% alcohol, it is determined that the risk of squamous cell carcinoma is high it can. Of course, the reference value may be set as appropriate according to the age, sex, race, etc. of the subject.
[0023]
The invention of this application further provides a simple determination device for determining the risk of squamous cell carcinoma from the concentration of acetaldehyde in exhaled breath. Such a simple determination device has a configuration as shown in FIG. That is, at least
(A) an exhalation introduction unit for introducing exhalation from a subject after ingesting a certain amount of alcohol at a certain concentration, (b) an acetaldehyde concentration measurement unit for measuring the acetaldehyde concentration of the introduced exhalation over time, and (c) A risk determination unit for determining the risk of squamous cell carcinoma from a change in acetaldehyde concentration with time, and (d) a risk index setting unit for setting an index for this determination and communicating it to the risk determination unit; ,
(E) It shall have a determination display part which displays the determination result from a risk determination part. In such a simple determination device, in the risk index setting unit (d), when the acetaldehyde concentration rapidly increases in the course of change with time, or when the degree of decrease in acetaldehyde concentration is smaller than a predetermined value, It is set as an index of “high risk”.
[0024]
In the apparatus for simple determination of the risk of occurrence of squamous cell carcinoma according to the invention of this application, exhalation is performed by injecting a predetermined amount of alcohol into a subject and then breathing into a commercially available sample bag for gas sampling, for example. Can be collected. Alternatively, in the case where the breath introduction unit of the simple determination device has a mouthpiece that can directly breathe, the subject may breathe in by placing the mouth on the mouthpiece. At this time, the amount of exhaled air collected is not particularly limited. The amount may be an amount that does not place a large burden on the subject, and can be appropriately changed according to the detection sensitivity of the acetaldehyde concentration measurement unit.
[0025]
In the case of collecting exhaled gas into the sample bag, the exhalation introducing part (a) in the apparatus for simple determination of the invention of this application can extract exhaled gas from the sample bag with a syringe, insert the syringe, and inject the collected exhaled gas It may be an insertion inlet, or may have a structure that allows the sample bag to be directly connected via a stopcock or the like. On the other hand, when inhaling exhaled breath directly into the device for simple determination, the mouthpiece may be a small diameter tube or straw that is contained in the mouth and breathes in, or a face mask that breathes into the mouth. There may be. It is preferable that these can be removed from the viewpoint of hygiene, can be sterilized, or disposable. Of course, these sample bags and mouthpieces may have filters, stopcocks, one-way valves, and the like.
[0026]
The introduced exhaled air is then transferred to the acetaldehyde concentration measurement unit (b), and the acetaldehyde concentration is measured over time. At this time, exhaled air may be transferred from the exhalation introduction unit to the acetaldehyde concentration measurement unit using an inert gas such as nitrogen or argon as a carrier gas, or exhalation may be convection and diffusion as it is. Such an acetaldehyde concentration measuring unit may have any configuration and structure as long as it can measure the concentration of acetaldehyde, and is not particularly limited. Specifically, a Breath Gas Analyzer improved for acetaldehyde, gas chromatography, a gas detector tube, a reagent-coated crystal tensioning device, and the like are exemplified.
[0027]
Breath Gas Analyzer is a device that measures the concentration of hydrogen and methane in exhaled breath, which has been used for diagnosis of lactose digestion and absorption disorders and diabetic gastrointestinal disorders. If this detection part is improved for acetaldehyde, it can be applied as an acetaldehyde concentration measurement part (b) for the simple determination device of the present invention. On the other hand, gas chromatography is based on the difference in the absorption and desorption speed of each component when a column made of stainless steel or glass is filled with a filler such as molecular sieves, silica gel, or porous resin beads. This is a method for separating, analyzing, and quantifying gases, and various types of column packs suitable for analyzing acetaldehyde can be selected. The gas detector tube is a simple method of analyzing the concentration based on the color tone change caused by the reaction between a specific reagent and a gas, and the measurement range of the acetaldehyde concentration of 0.1 ppm to 20 ppm by the color tone change such as yellow → red. A wide variety of products such as those that can be measured for 1 to 10 hours are commercially available. Since the gas detection tube cannot be used repeatedly, it is disposable every time, but it can be said to be a simple and effective means if an amount of exhalation corresponding to the measurement range can be collected. Furthermore, the reagent-applied quartz crystal slidator applies a reagent such as a Schiff base that specifically reacts with acetaldehyde to the surface of the vibrator and detects a change in oscillation frequency that occurs when acetaldehyde reacts. In the invention of this application, gas chromatography having high measurement accuracy and a wide measurement concentration range is preferably used as the acetaldehyde concentration measurement unit.
[0028]
The measurement result in the acetaldehyde concentration measurement unit (b) as described above is transmitted to the risk determination unit (c) as an electric signal or the like by the signal transmission means. Then, in this risk determination unit (c), the risk of occurrence of squamous cell carcinoma is determined from the change in the acetaldehyde concentration with time.
[0029]
Such a risk determination unit (c) can be, for example, a computer, and the value of the acetaldehyde concentration in the breath measured by the acetaldehyde concentration measurement unit (b) over time is set as a risk index setting part (d). It is possible to compare and judge the index set as input. The risk index input and set in the risk index setting part (d) is a combination of genetic polymorphisms of ADH3-2 (−) / ALDH2-2 (−), ADH3-2 (+) / ALDH2-2. (−), ADH3-2 (−) / ALDH2-2 (+), ADH3-2 (+) / ALDH2-2 (+) subjects were measured comprehensively under the same conditions, and the results were Can be set to the original. In addition, the setting can be changed at any time according to the age, sex, race, etc. of the subject, and is not particularly limited.
[0030]
In such a risk index setting part (d), when the acetaldehyde concentration shows a rapid increase in the process of change with time or a decrease degree smaller than a predetermined decrease degree, the risk degree is set to be high. According to the earnest study by the inventors, it can be set that the risk of squamous cell carcinoma is high when the concentration of acetaldehyde in the breath does not become 10 nmol or less after 30 minutes have elapsed after ingesting 200 ml of 6% alcohol.
[0031]
The determination result is further transmitted to the determination display section (e) by the signal transmission means and displayed. At this time, as the judgment display part (e), a numerical value or graph is displayed as an image like a liquid crystal monitor or a CRT monitor, a sound is output like a speaker, and a printer is used. Examples where the result is printed on the paper are illustrated.
[0032]
The apparatus for simple determination of the risk of occurrence of squamous cell carcinoma as described above has at least the configuration as described above, but also emits voice, characters, signals, images, etc. instructing the subject to breathe in. You may have a display means etc. which show a test means and a measurement progress to a test subject or an operator. Such a simple determination device can be moved and carried by reducing the size of each component. This makes it possible to measure the risk of epithelial cancer occurrence quantitatively, quickly, simply, and with high accuracy.
[0033]
【Example】
<Example 1>
78 subjects who passed 2 hours or more after meals were ingested with 200 ml of grapefruit juice containing 6% alcohol over 10 minutes. Of the 78, 26 were unable to participate in the test due to strong alcohol intolerance.
[0034]
Therefore, for the remaining 52 people, exhaled breath was collected with an exhalation collection pack before alcohol intake, immediately after ingestion, 10 minutes later and 30 minutes later, and gas chromatography (column: Polapack Q60 / 80 glass column 3 mm × 2 m; GL Science Acetaldehyde concentration in 1 ml of exhaled breath was analyzed by a company, detector: FID, carrier gas: helium, flow rate: 40 mlmin.
[0035]
The results are shown in FIG.
[0036]
Acetaldehyde, which was not detected at all before alcohol intake, was detected immediately after drinking. Moreover, the difference was seen by the peak value and the value after 10 minutes and 30 minutes by the combination of gene polymorphism allele.
[0037]
Specifically, the combinations of gene polymorphisms are ADH3-2 (−) / ALDH2-2 (−), ADH3-2 (+) / ALDH2-2 (−), ADH3-2 (−) / ALDH2-2 ( +) And ADH3-2 (+) / ALDH2-2 (+) in the order of increasing acetaldehyde concentration.
[0038]
Since the risk of occurrence of multiple atypical epithelium also increased significantly in the same order, it was shown that the risk of occurrence of squamous cell carcinoma can be accurately predicted by measuring the concentration of acetaldehyde in exhaled breath. It was also shown that high risk groups with multiple cancers can be found with high accuracy. That is, as shown in FIG. 2, when the combinations of gene polymorphisms are ADH3-2 (−) / ALDH2-2 (−) and ADH3-2 (+) / ALDH2-2 (−), 30 minutes later It was determined that the acetaldehyde concentration in exhaled breath was 10 nmol or less and the risk of squamous cell carcinoma was low. On the other hand, when the combination of gene polymorphisms is ADH3-2 (−) / ALDH2-2 (+) and ADH3-2 (+) / ALDH2-2 (+), the concentration of acetaldehyde in exhaled breath is 10 nmol even after 30 minutes. Since it was not below (both were maintained at 50 nmol or more), it could be determined that the risk of squamous cell carcinoma was high.
[0039]
【The invention's effect】
As described in detail above, the invention of this application provides a simple determination method and determination apparatus that allow a subject to diagnose the risk of developing squamous cell carcinoma by measuring the aldehyde concentration in exhaled breath.
[0040]
Such a method for determining the risk of squamous cell carcinoma development does not require genetic testing, enables quantitative and non-invasive evaluation in a short time, and requires expensive genetic analysis equipment and complicated operations Therefore, it can be easily introduced in small clinics and clinics, is easily accepted by society, and is expected to raise social interest in cancer prevention.
[0041]
In addition, the device for determining the risk of occurrence of squamous cell carcinoma of the present application not only makes it possible to easily measure the risk of the occurrence of squamous cell carcinoma, but also makes it possible to obtain a portable device for simple determination by downsizing. . With such a small simple determination device, it becomes possible to quickly determine the risk of squamous cell carcinoma occurrence at any medical site, and it is expected that cancer prevention will more commonly permeate.
[0042]
If the subject himself / herself recognizes whether or not the risk of carcinogenesis is high, it becomes possible to tackle specific and effective cancer prevention, and thus the present invention is highly useful.
[Brief description of the drawings]
FIG. 1 is a schematic diagram showing an outline of a device for simple determination of the risk of occurrence of squamous cell carcinoma in the invention of this application.
FIG. 2 is a graph showing the relationship between the acetaldehyde concentration in exhaled breath due to alcohol intake and the combination of ADH3 and ALDH2 gene polymorphisms in the examples of the invention of this application.

Claims (4)

一定濃度のアルコールを一定量摂取した後、呼気中のアセトアルデヒド濃度の経時変化を測定し、アセトアルデヒド濃度の急激な上昇が見られた場合や、時間経過によるアセトアルデヒド濃度の減少度が小さい場合に、扁平上皮癌発生の危険度が高いと判定することを特徴とする扁平上皮癌発生危険度の簡易判定方法。After ingesting a certain amount of alcohol at a certain concentration, measure changes over time in the acetaldehyde concentration in exhaled breath. A simple determination method for the risk of occurrence of squamous cell carcinoma, characterized by determining that the risk of occurrence of epithelial cancer is high. 一定濃度のアルコールを一定量摂取した後、呼気中のアセトアルデヒド濃度の経時変化を測定し、30分以内にアセトアルデヒド濃度が10nmol以下にならないとき、扁平上皮癌発生の危険度が高いと判定する請求項1の扁平上皮癌発生危険度の簡易判定方法。Claims: After ingesting a certain amount of alcohol at a certain concentration, the time-dependent change in acetaldehyde concentration in exhaled breath is measured, and if the acetaldehyde concentration does not fall below 10 nmol within 30 minutes, it is determined that the risk of developing squamous cell carcinoma is high 1. A simple determination method for the risk of squamous cell carcinoma occurrence of 1. 呼気により扁平上皮癌発生の危険度を判定するための簡易判定用装置であって、少なくとも、
一定濃度のアルコールを一定量摂取した後の被験者からの呼気が導入される呼気導入部と
導入された呼気のアセトアルデヒド濃度を経時的に測定するアセトアルデヒド濃度測定部と
アセトアルデヒド濃度の経時的変化から扁平上皮癌発生の危険度を判定するための危険度判定部と
この判定のための指標を設定し、危険度判定部に伝える危険度指標設定部と、
危険度判定部からの判定結果を表示する判定表示部とを有し、
危険度指標設定部においては、アセトアルデヒド濃度が経時変化の過程で急激な上昇かもしくは所定の減少度より小さい減少度を示す場合に、危険度が高いとして指標設定されていることを特徴とする扁平上皮癌発生危険度の簡易判定用装置。
A simple determination device for determining the risk of squamous cell carcinoma occurrence by exhalation, at least,
A breath induction part that introduces exhaled breath from a subject after ingesting a constant amount of alcohol, an acetaldehyde concentration measurement part that measures the acetaldehyde concentration of the introduced breath over time, and squamous epithelium from changes in acetaldehyde concentration over time A risk level determination unit for determining the risk level of cancer occurrence and an index for this determination, a risk level index setting unit to be transmitted to the risk level determination unit,
A determination display unit that displays a determination result from the risk determination unit,
In the risk index setting unit, when the acetaldehyde concentration shows a rapid increase in the course of change over time or a decrease level smaller than a predetermined decrease level, the risk level is set as a high risk level. Device for simple determination of epithelial cancer risk.
30分以内にアセトアルデヒド濃度が10nmol以下になることを所定の減少度とする請求項3の扁平上皮癌発生危険度の簡易判定用装置。The apparatus for simple determination of the risk of occurrence of squamous cell carcinoma according to claim 3, wherein the predetermined decrease is that the acetaldehyde concentration becomes 10 nmol or less within 30 minutes.
JP2002011053A 2002-01-21 2002-01-21 Simple determination method of risk of squamous cell carcinoma occurrence by exhalation and apparatus for the same Expired - Fee Related JP3790792B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002011053A JP3790792B2 (en) 2002-01-21 2002-01-21 Simple determination method of risk of squamous cell carcinoma occurrence by exhalation and apparatus for the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002011053A JP3790792B2 (en) 2002-01-21 2002-01-21 Simple determination method of risk of squamous cell carcinoma occurrence by exhalation and apparatus for the same

Publications (2)

Publication Number Publication Date
JP2003215123A JP2003215123A (en) 2003-07-30
JP3790792B2 true JP3790792B2 (en) 2006-06-28

Family

ID=27648621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002011053A Expired - Fee Related JP3790792B2 (en) 2002-01-21 2002-01-21 Simple determination method of risk of squamous cell carcinoma occurrence by exhalation and apparatus for the same

Country Status (1)

Country Link
JP (1) JP3790792B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015064063A1 (en) * 2013-10-31 2015-05-07 国立大学法人京都大学 Method for determining aldehyde-degrading enzyme activity genotype, method for determining squamous epithelial cancer onset risk, device for determining squamous epithelial cancer onset risk, and program
US20210341461A1 (en) * 2018-09-04 2021-11-04 Owlstone Medical Limited Diagnosis of cancer

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004233061A (en) * 2003-01-28 2004-08-19 National Cancer Center-Japan Continuous concentrated gas sampling apparatus by nebulizer-denuder interlocking, and gas analysis apparatus incorporating the gas sampling apparatus and analysis method
JP2008122211A (en) * 2006-11-11 2008-05-29 National Cancer Center-Japan Method and device for simply determining risk group of squamous cell carcinoma by exhalation, and its tube for fractional separation of 13c acetaldehyde

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015064063A1 (en) * 2013-10-31 2015-05-07 国立大学法人京都大学 Method for determining aldehyde-degrading enzyme activity genotype, method for determining squamous epithelial cancer onset risk, device for determining squamous epithelial cancer onset risk, and program
CN105849558A (en) * 2013-10-31 2016-08-10 国立大学法人京都大学 Method for determining aldehyde-degrading enzyme activity genotype, method for determining squamous epithelial cancer onset risk, device for determining squamous epithelial cancer onset risk, and program
JP6001192B2 (en) * 2013-10-31 2016-10-05 国立大学法人京都大学 Aldehyde-degrading enzyme activity genotype determination device, squamous cell carcinoma occurrence risk determination device, and program
CN105849558B (en) * 2013-10-31 2019-01-18 国立大学法人京都大学 Aldehyde catabolic enzyme active gene type judgment method, squamous cell carcinoma degree of causing danger judgment method, squamous cell carcinoma degree of causing danger judgment means and program
US20210341461A1 (en) * 2018-09-04 2021-11-04 Owlstone Medical Limited Diagnosis of cancer

Also Published As

Publication number Publication date
JP2003215123A (en) 2003-07-30

Similar Documents

Publication Publication Date Title
Tepper et al. Asthma outcomes: pulmonary physiology
US8485984B2 (en) Portable breath collection system for use in breath tests
JP5085653B2 (en) Condensed glue course analyzer
US20030208133A1 (en) Breath ketone analyzer
EP3863514B1 (en) Self-contained wearable metabolic analyzer
Ball et al. Allergen bronchoprovocation of patients with mild allergic asthma after ozone exposure
Khandpur Compendium of Biomedical Instrumentation, 3 Volume Set
JP2010148692A (en) Method and apparatus for detecting surface gas
JP2006068533A (en) Lung function diagnostic device using ultrasound and lung function diagnostic method using the same
Lazovic et al. Comparison of lung diffusing capacity in young elite athletes and their counterparts
US20160143561A1 (en) Self-contained, portable h2/co2 (air) ratio apparatus
JP3790792B2 (en) Simple determination method of risk of squamous cell carcinoma occurrence by exhalation and apparatus for the same
Barberan‐Garcia et al. Training‐induced changes on quadriceps muscle oxygenation measured by near‐infrared spectroscopy in healthy subjects and in chronic obstructive pulmonary disease patients
JP2004279228A (en) Method and apparatus for measuring concentration of component gas in exhalation
EP0253927A1 (en) A breath test for measuring urease activity in the stomach using carbon isotope urea
Zellner et al. Differences in respiratory muscle strength measures in well-nourished and malnourished hospitalized patients
Ruzsanyi et al. Origin and Emission of Volatile Biomarkers in Breath: End-tidal Perspective
Guthrie et al. End‐tidal carbon dioxide measurements in children with acute asthma
Rahnama’i et al. Which clinical signs and symptoms predict hypoxemia in acute childhood asthma?
Takeda et al. Correlation of salivary amylase activity with eustress in patients with severe motor and intellectual disabilities
JPWO2015064063A1 (en) Aldehyde-degrading enzyme activity genotype determination device, squamous cell carcinoma occurrence risk determination device, and program
MacNee et al. Fast facts: chronic obstructive pulmonary disease
Aufderhaar Breath Analysis as Part of Pulmonary Function Diagnostics
JP2015102414A (en) Detection method and tool of helicobacter pylori
US20240237913A1 (en) Portable breath analysis device system and a method thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20031205

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20031031

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20040129

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040319

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040730

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040730

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041029

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041029

A072 Dismissal of procedure

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20041228

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20050708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050809

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051007

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060207

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060306

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100414

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100414

Year of fee payment: 4

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110414

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110414

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees